Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

A network module-based method for identifying cancer prognostic signatures.

Wu G, Stein L.

Genome Biol. 2012 Dec 10;13(12):R112. doi: 10.1186/gb-2012-13-12-r112.

PMID:
23228031
[PubMed - in process]
Free PMC Article
2.

Protein interaction network underpins concordant prognosis among heterogeneous breast cancer signatures.

Chen J, Sam L, Huang Y, Lee Y, Li J, Liu Y, Xing HR, Lussier YA.

J Biomed Inform. 2010 Jun;43(3):385-96. doi: 10.1016/j.jbi.2010.03.009. Epub 2010 Mar 27.

PMID:
20350617
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Breast cancer biomarker discovery in the functional genomic age: a systematic review of 42 gene expression signatures.

Abba MC, Lacunza E, Butti M, Aldaz CM.

Biomark Insights. 2010 Oct 27;5:103-18. doi: 10.4137/BMI.S5740.

PMID:
21082037
[PubMed]
Free PMC Article
4.

Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment.

Zhang W, Ota T, Shridhar V, Chien J, Wu B, Kuang R.

PLoS Comput Biol. 2013;9(3):e1002975. doi: 10.1371/journal.pcbi.1002975. Epub 2013 Mar 21.

PMID:
23555212
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Network based consensus gene signatures for biomarker discovery in breast cancer.

Fröhlich H.

PLoS One. 2011;6(10):e25364. doi: 10.1371/journal.pone.0025364. Epub 2011 Oct 25.

PMID:
22046239
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.

Karn T, Pusztai L, Holtrich U, Iwamoto T, Shiang CY, Schmidt M, Müller V, Solbach C, Gaetje R, Hanker L, Ahr A, Liedtke C, Ruckhäberle E, Kaufmann M, Rody A.

PLoS One. 2011;6(12):e28403. doi: 10.1371/journal.pone.0028403. Epub 2011 Dec 29.

PMID:
22220191
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A gene-expression signature to predict survival in breast cancer across independent data sets.

Naderi A, Teschendorff AE, Barbosa-Morais NL, Pinder SE, Green AR, Powe DG, Robertson JF, Aparicio S, Ellis IO, Brenton JD, Caldas C.

Oncogene. 2007 Mar 1;26(10):1507-16. Epub 2006 Aug 28.

PMID:
16936776
[PubMed - indexed for MEDLINE]
8.

Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature.

De Preter K, Vermeulen J, Brors B, Delattre O, Eggert A, Fischer M, Janoueix-Lerosey I, Lavarino C, Maris JM, Mora J, Nakagawara A, Oberthuer A, Ohira M, Schleiermacher G, Schramm A, Schulte JH, Wang Q, Westermann F, Speleman F, Vandesompele J.

Clin Cancer Res. 2010 Mar 1;16(5):1532-41. doi: 10.1158/1078-0432.CCR-09-2607. Epub 2010 Feb 23.

PMID:
20179214
[PubMed - indexed for MEDLINE]
Free Article
9.

Significance analysis of prognostic signatures.

Beck AH, Knoblauch NW, Hefti MM, Kaplan J, Schnitt SJ, Culhane AC, Schroeder MS, Risch T, Quackenbush J, Haibe-Kains B.

PLoS Comput Biol. 2013;9(1):e1002875. doi: 10.1371/journal.pcbi.1002875. Epub 2013 Jan 24.

PMID:
23365551
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Co-expression module analysis reveals biological processes, genomic gain, and regulatory mechanisms associated with breast cancer progression.

Shi Z, Derow CK, Zhang B.

BMC Syst Biol. 2010 May 27;4:74. doi: 10.1186/1752-0509-4-74.

PMID:
20507583
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Network analysis of gene lists for finding reproducible prognostic breast cancer gene signatures.

Kairov U, Karpenyuk T, Ramanculov E, Zinovyev A.

Bioinformation. 2012;8(16):773-6. doi: 10.6026/97320630008773. Epub 2012 Aug 24.

PMID:
23055628
[PubMed]
Free PMC Article
12.

Identification of high-quality cancer prognostic markers and metastasis network modules.

Li J, Lenferink AE, Deng Y, Collins C, Cui Q, Purisima EO, O'Connor-McCourt MD, Wang E.

Nat Commun. 2010 Jul 13;1:34. doi: 10.1038/ncomms1033. Erratum in: Nat Commun. 2012;3. doi:10.1038/ncomms1033.

PMID:
20975711
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

HyperModules: identifying clinically and phenotypically significant network modules with disease mutations for biomarker discovery.

Leung A, Bader GD, Reimand J.

Bioinformatics. 2014 Aug 1;30(15):2230-2. doi: 10.1093/bioinformatics/btu172. Epub 2014 Apr 8.

PMID:
24713437
[PubMed - in process]
Free PMC Article
14.

Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules.

Teschendorff AE, Gomez S, Arenas A, El-Ashry D, Schmidt M, Gehrmann M, Caldas C.

BMC Cancer. 2010 Nov 4;10:604. doi: 10.1186/1471-2407-10-604.

PMID:
21050467
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer.

Yau C, Esserman L, Moore DH, Waldman F, Sninsky J, Benz CC.

Breast Cancer Res. 2010;12(5):R85. doi: 10.1186/bcr2753. Epub 2010 Oct 14.

PMID:
20946665
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

NOA: a cytoscape plugin for network ontology analysis.

Zhang C, Wang J, Hanspers K, Xu D, Chen L, Pico AR.

Bioinformatics. 2013 Aug 15;29(16):2066-7. doi: 10.1093/bioinformatics/btt334. Epub 2013 Jun 7.

PMID:
23749961
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients.

Shi M, Beauchamp RD, Zhang B.

PLoS One. 2012;7(7):e41292. doi: 10.1371/journal.pone.0041292. Epub 2012 Jul 23.

PMID:
22844451
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types.

Staub E, Groene J, Heinze M, Mennerich D, Roepcke S, Klaman I, Hinzmann B, Castanos-Velez E, Pilarsky C, Mann B, Brümmendorf T, Weber B, Buhr HJ, Rosenthal A.

J Mol Med (Berl). 2009 Jun;87(6):633-44. doi: 10.1007/s00109-009-0467-y. Epub 2009 Apr 28.

PMID:
19399471
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Using protein interaction database and support vector machines to improve gene signatures for prediction of breast cancer recurrence.

Sehhati MR, Dehnavi AM, Rabbani H, Javanmard SH.

J Med Signals Sens. 2013 Apr;3(2):87-93.

PMID:
24098862
[PubMed]
Free PMC Article
20.

Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?

Tímár J, Gyorffy B, Rásó E.

Clin Exp Metastasis. 2010 Aug;27(6):371-87. doi: 10.1007/s10585-010-9307-2. Epub 2010 Feb 24. Review.

PMID:
20177751
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk